Raffeld M - Search Results

1

Modulation of clinical drug resistance in a B cell lymphoma patient by the protein kinase inhibitor 7-hydroxystaurosporine: presentation of a novel therapeutic paradigm.

Wilson WH, Sorbara L, Figg WD, Mont EK, Sausville E, Warren KE, Balis FM, Bauer K, Raffeld M, Senderowicz AM, Monks A. Wilson WH, et al. Among authors: raffeld m. Clin Cancer Res. 2000 Feb;6(2):415-21. Clin Cancer Res. 2000. PMID: 10690518

2

Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.

Longo DL, Duffey PL, Jaffe ES, Raffeld M, Hubbard SM, Fisher RI, Wittes RE, DeVita VT Jr, Young RC. Longo DL, et al. Among authors: raffeld m. J Clin Oncol. 1994 Oct;12(10):2153-9. doi: 10.1200/JCO.1994.12.10.2153. J Clin Oncol. 1994. PMID: 7523607 Clinical Trial.

3

Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas.

Otsuki T, Clark HM, Wellmann A, Jaffe ES, Raffeld M. Otsuki T, et al. Among authors: raffeld m. Cancer Res. 1995 Apr 1;55(7):1436-40. Cancer Res. 1995. PMID: 7882348

4

S-100-positive T-cell lymphoproliferative disorder. A case report and review of the literature.

Zarate-Osorno A, Raffeld M, Berman EL, Ferguson MM, Andrade R, Jaffe ES. Zarate-Osorno A, et al. Among authors: raffeld m. Am J Clin Pathol. 1994 Oct;102(4):478-82. doi: 10.1093/ajcp/102.4.478. Am J Clin Pathol. 1994. PMID: 7942605

5

Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.

Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Wilson WH, et al. Among authors: raffeld m. Blood. 1996 Jun 1;87(11):4531-7. Blood. 1996. PMID: 8639820 Free article.

6

Marginal zone B-cell lymphoma with monocytoid B-cell lymphocytes in pediatric patients without immunodeficiency. A report of two cases.

Elenitoba-Johnson KS, Kumar S, Lim MS, Kingma DW, Raffeld M, Jaffe ES. Elenitoba-Johnson KS, et al. Among authors: raffeld m. Am J Clin Pathol. 1997 Jan;107(1):92-8. doi: 10.1093/ajcp/107.1.92. Am J Clin Pathol. 1997. PMID: 8980374

7

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.

Wilson WH, Teruya-Feldstein J, Fest T, Harris C, Steinberg SM, Jaffe ES, Raffeld M. Wilson WH, et al. Among authors: raffeld m. Blood. 1997 Jan 15;89(2):601-9. Blood. 1997. PMID: 9002964 Free article.

8

Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.

Krenacs L, Wellmann A, Sorbara L, Himmelmann AW, Bagdi E, Jaffe ES, Raffeld M. Krenacs L, et al. Among authors: raffeld m. Blood. 1997 Feb 1;89(3):980-9. Blood. 1997. PMID: 9028330 Free article.

9

Histologically discordant lymphomas with B-cell and T-cell components.

Abruzzo LV, Griffith LM, Nandedkar M, Aguilera NS, Taubenberger JK, Raffeld M, Stass SA, Abbondanzo SL, Jaffe ES. Abruzzo LV, et al. Among authors: raffeld m. Am J Clin Pathol. 1997 Sep;108(3):316-23. doi: 10.1093/ajcp/108.3.316. Am J Clin Pathol. 1997. PMID: 9291461

10

Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.

Kumar S, Krenacs L, Medeiros J, Elenitoba-Johnson KS, Greiner TC, Sorbara L, Kingma DW, Raffeld M, Jaffe ES. Kumar S, et al. Among authors: raffeld m. Hum Pathol. 1998 Apr;29(4):397-403. doi: 10.1016/s0046-8177(98)90122-8. Hum Pathol. 1998. PMID: 9563791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters